Strong Revenue Growth: GE HealthCare reported revenues of $5 billion in Q2 2025, achieving organic growth of 2% year-over-year, with service revenues growing 7% and product revenues up 2%. The robust performance reflects healthy customer demand and execution across all segments, particularly in the U.S. and EMEA regions.

Record Backlog and Orders Growth: The company experienced a record backlog of $21.3 billion, up $2.2 billion from the previous year and strong organic orders growth of 3% year-over-year. This positions GE HealthCare favorably for continued revenue generation and supports the expectation of mid-single-digit growth moving forward.

Adjusted EPS Guidance Increase: GE HealthCare raised its full-year adjusted EPS guidance to a range of $4.43 to $4.63, up from the previous guidance of $3.90 to $4.10. This increase reflects strong operational performance and improved tax rates, despite the continued impact from tariffs.